High incidence rate of human herpesvirus 6 infection after Bendamustine, Cytarabine, Etoposide and Melphalan conditioning regimen: A monocentric and retrospective study
<p>Background: Following shortage of Carmustine, BeEAM regimen (Bendamustine, Etoposide, Cytarabine and Melphalan) was used before autologous transplant in relapsed/refractory lymphoma patients. We evaluated safety and efficacy of BeEAM compared to BEAM.</p><p>Patients and methods:...
Saved in:
Main Authors: | Simon Favre (Author), Mathieu Sauvezie (Author), Stéphane Vigouroux (Author), Reza Tabrizi (Author), Marie-Sarah Dilhuydy (Author), Gaelle Laboure (Author), Margot Robles (Author), Noel Milpied (Author), Kamal Bouabdallah (Author) |
---|---|
Format: | Book |
Published: |
Archives of Clinical Nephrology - Peertechz Publications,
2021-06-14.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Apoptotic colopathy following bendamustine therapy
by: Vincent Czerwinski, et al.
Published: (2023) -
Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implants
by: Chunsheng Wu, et al.
Published: (2020) -
Herpetic esophagitis following bendamustine-containing regimen
by: Yamane H, et al.
Published: (2016) -
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
by: Morabito F, et al.
Published: (2021) -
Etoposide Therapy for Recurrent Gliomas
by: J Gordon Millichap
Published: (1997)